References
- Asano, N. 2003. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13, 93R-104R https://doi.org/10.1093/glycob/cwg090
- Asano, N., K. Oseki, H. Kizu, and K. Matsui. 1994. Nitrogen-inthe- ring pyranoses and furanoses: structural basis of inhibition of mammalian glycosidases. J. Med. Chem. 37, 3701-3706 https://doi.org/10.1021/jm00048a006
- Asano, N., K. Oseki, E. Tomioka, H. Kizu, and K. Matsui. 1994. N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydr. Res. 259, 243-255 https://doi.org/10.1016/0008-6215(94)84060-1
- Asano, N., T. Yamashita, K. Yasuda, K. Ikeda, H. Kizu, Y. Kameda, A. Kato, R.J. Nash, H.S. Lee, and K.S. Ryu. 2001. Polyhydroxylated alkaloids isolated from Mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem. 49, 4208-4213 https://doi.org/10.1021/jf010567e
- Beames, B., D. Chavez, B. Guerra, L. Notvall, K.M. Brasky, and R.E. Lanford. 2000. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J. Virol. 74, 11764-11772 https://doi.org/10.1128/JVI.74.24.11764-11772.2000
- Block, T.M., X. Lu, A.S. Mehta, B.S. Blumberg, B.C. Tennant, M. Ebling, B. Korba, D.M. Lansky, G.S. Jacob, and R.A. Dwek. 1998. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nature Med. 4, 610-614 https://doi.org/10.1038/nm0598-610
- Block, T.M., X. Lu, F.M. Platt, G.R. Foster, W.H. Gerlich, B.S. Blumber, and R.A. Dwek. 1994. Secretion of hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. USA 91, 2235-2239
- Branza-Nichita, N., D. Durantel, S. Carrouee-Durantel, R.A. Dwek, and N. Zitzmann. 2001. Antiviral effects of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers. J. Virol. 75, 3527-3536 https://doi.org/10.1128/JVI.75.8.3527-3536.2001
- Cavalletto, L., L. Chemello, C. Donada, P. Casarin, F. Belussi, E. Bernardinello, F. Marino, P. Pontisso, A. Gatta, and A. Alberti. 2000. The pattern of response to interferon alpha predicts sustained response to a 6-month alpha-INF and ribavirin retreatment for chronic hepatitis C. J. Hepatol. 33, 128-134 https://doi.org/10.1016/S0168-8278(00)80169-5
- Chisari, F.V. and C. Ferrari. 1997. Viral hepatitis, p. 745-778. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, PA, USA
- Chou, T.C. and P. Talalay. 1984. Quantitative Analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Reg. 22, 27-55 https://doi.org/10.1016/0065-2571(84)90007-4
- Corapi, W.V., R.O. Donis, and E.J. Dubovi. 1990. Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus. Am. J. Vet. Res. 51, 1388-1394
- Crespo, J., J.L. Lozano, B. Carte, B. De Las Heras, F. De La Cruz, and F. Pons-Romero. 1997. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur. J. Clin. Infect. Dis. 16, 445-451 https://doi.org/10.1007/BF02471908
- Di Bisceglie, A.M. and B.R. Bacon. 1999. The unmet challenges of hepatitis C. Scientific American 281, 80-85
- Dobrinski, I., J.R. Jacob, B.C. Tennant, and B. Ball. 1999. Generation of an equine oviductal epithelial cell line for the study of sperm-oviduct interaction. Theriogenology 52, 875-885 https://doi.org/10.1016/S0093-691X(99)00179-X
- Durantel, D., N. Branza-Nichita, S. Carrouee-Durantel, T.D. Butters, R.A. Dwek, and N. Zitzmann. 2001. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J. Virol. 75, 8987-8998 https://doi.org/10.1128/JVI.75.19.8987-8998.2001
- Hoofnagle, J.H. and A.M. Di Bisceglie. 1997. The treatment of chronic viral hepatitis. New Engl. J. Med. 336, 337-356 https://doi.org/10.1056/NEJM199701303360504
- Jacob, G.S. 1995. Gylcosylation inhibitors in biology and medicine. Curr. Opin. Struct. Bool. 5, 605-611 https://doi.org/10.1016/0959-440X(95)80051-4
- Jacob, J.R., R.H. Liu, C. Roneker, F. Noronha, J.H. Hotchkiss, and B.C. Tennant. 1994. Characterization and immortalization of woodchuck hepatocytes isolated from normal and hepadnavirus infected woodchucks (Marmota monax). Exp. Cell Res. 212, 42-48 https://doi.org/10.1006/excr.1994.1116
- Jacob, J.R., I. Toshkov, B.E. Korba, P.J. Cote, W. DeLaney, J.L. Gerin, and B.C. Tennant. 2004. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral Res. In press
- Jarvis, B. and D. Faulds. 1999. Lamivudine. A review of its therapeutic potential in chronic hepatitis B. Drugs 58, 101-141 https://doi.org/10.2165/00003495-199958010-00015
- Jassim, S.A.A. and M.A. Naji. 2003. Novel antiviral agents: a medicinal plant perspective. J. Appl. Micro. 95, 412-427 https://doi.org/10.1046/j.1365-2672.2003.02026.x
- Jen, J., M. Laughlin, C. Chung, S. Heft, M.B. Affrime, S.K. Gupta, P. Glue, and G. Hajian. 2002. Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models. Clin. Pharmacol. Therapeutics 72, 349-361 https://doi.org/10.1067/mcp.2002.127112
- Joubert, P.H., C.P. Venter, H.F. Joubert, and I. Hillebrand. 1985. The effect of 1-deoxynojirimycin derivative on post-pradial blood glucose and insulin levels in healthy black and white volunteers. Eur. J. Clin. Pharmacol. 28, 705-708 https://doi.org/10.1007/BF00607920
- Khakoo, S., P.G. Glue, L. Grellier, B. Wells, A. Bell, C. Dash, I. Murray-Lyon, D. Lypnyj, B. Flannery, K. Walters, and G.M. Dusheiko. 1998. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br. J. Clin. Pharmacol. 46, 563-570 https://doi.org/10.1046/j.1365-2125.1998.00836.x
- Kimura, M., F.J. Chen, N. Nakashima, I. Kimura, N. Asano, and S. Koya. 1995. Antihyperglycemic effects of N-containing sugars derived from Mulberry leaves in streptozocin-induced diabetic mice. J. Trad. Med. 12, 214-219
- Korba, B.E. and J.L. Gerin. 1992. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 19, 55-70 https://doi.org/10.1016/0166-3542(92)90056-B
- Lanford, R.E., D. Chavez, B. Guerra, J.Y.N. Lau, Z. Hong, K.M. Brasky, and B. Beames. 2001. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J. Virol. 75, 8074-8081 https://doi.org/10.1128/JVI.75.17.8074-8081.2001
- Liang, T.J. 1999. Complementary and alternative medicine: The roots of healing. Gastroenterology 117, 1041 https://doi.org/10.1016/S0016-5085(99)70385-9
- Liaw, Y.F. 2001. Concurrent hepatitis B and C virus infection: is hepatitis C virus stronger? J. Gastroenterol. Hepatol. 16, 597-598 https://doi.org/10.1046/j.1440-1746.2001.02523.x
- Liu, J., L. Kjaergard, and C. Glund. 2002. Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B. Amer. J. Chinese Med. 30, 173-176 https://doi.org/10.1142/S0192415X0200017X
- Look, M.P., A. Gerard, G.S. Rao, T. Sudhop, H.P. Fischer, T. Sauerbruch, and U. Spengler. 1999. Interferon/antioxidant combination therapy for chronic hepatitis C-a controlled pilot trial. Antiviral Res. 43, 113-122 https://doi.org/10.1016/S0166-3542(99)00041-8
- Lu, X., A. Mehta, R. Dwek, T. Butters, and T. Block. 1995. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virol. 213, 660-665 https://doi.org/10.1006/viro.1995.0038
- Martin, K.W. and E. Ernest. 2003. Antiviral agents from plants and herbs; a systemic review. Antivir. Ther. 8, 77-90
- McHutchison, J.G., S.C. Gordon, E.R. Schiff, M.L. Shiffman, W.M. Lee, V.K. Rustgi, Z.D. Goodman, M.H. Ling, S. Cort, and J.K. Albrecht. 1998. Interferon alpha 2a alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New England J. Med. 339, 1485-1492 https://doi.org/10.1056/NEJM199811193392101
- Mehta, A., B. Conyers, D.L.J. Tyrrell, K.A. Walters, G.A. Tipples, R. Dwek, and T.M. Block. 2002. Structure-activity relationship of a new class of anti-hepatitis B virus agents. Antimicro. Agents Chemo. 46, 4004-4008 https://doi.org/10.1128/AAC.46.12.4004-4008.2002
-
Ouzounzov, S., A.D. Menta, T.M. Block, and R. Jordan. 2002. The combination of interferon
${\alpha}$ -2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Res. 55, 425-435 https://doi.org/10.1016/S0166-3542(02)00075-X - Pestka, S. 1986. Interferon standards and general abbreviations. Meth. Enzymol. 119, 14-23 https://doi.org/10.1016/0076-6879(86)19004-5
- Schuppan, D., J.D. Jia, B. Brinhaus, and E.G. Hann, 1999. Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology 30, 1099-1104 https://doi.org/10.1002/hep.510300437
- Schvarcz, R., Z.B. Yun, A. Sonnerborg, and O. Weiland. 1995. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J. Med. Virol. 46, 43-47 https://doi.org/10.1002/jmv.1890460110
- Seeff, L.B., K.L. Lindsay, B.R. Bacon, T.F. Kresina, and J.H. Hoofnagle. 2001. Complementary and alternative medicine in chronic liver disease. Hepatology 34, 595-603 https://doi.org/10.1053/jhep.2001.27445
- Stephensen, C.B., J.R. Jacob, R.J. Montali, R.J. Montali, E.D. Armes, M.J. Buchmeler, E. Muchmore, K.V. Holmes, and R.E. Lanford. 1991. Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease. J. Virol. 65, 3995-4000
- Strader, D.B. and H.J. Zimmerman. 2000. Complementary and alternative medicine in Hepatitis C, p. 363-386. In T.J. Liang and J.H. Hoofnagle (ed.), Biomedical Research Reports; Hepatitis C. Academic Press, New York, NY, USA
- Tolle, T.K., D. Glebe, M. Linder, D. Linder, S. Schmitt, R. Geyer, and W.H. Gerlich. 1998. Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus. J. Virol. 72, 9978-9985
- Tsiang, M., J.F. Roonex, J.J. Toole, and G.S. Gibbs. 1999. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 29, 1863-1869 https://doi.org/10.1002/hep.510290626
- Vilcek, J. and G.C. Sen. 1996. Interferons and other cytokines, p. 375-399. In B.N. Fields, D.M. Knipe, and P.M. Howley (ed.), Fields Virology. Lippincott-Raven Publishers, Philadelphia, PA, USA
- Wu, S.F., C.J. Lee, C.L. Liao, R.A. Dwek, N. Zitzmann, and Y.L. Lin. 2002. Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 67, 3596-3604
- Zitzmann, N., A.S. Mehta, S. Carrouee, T.D. Butters, F.M. Platt, J. McCauley, B.S. Blumberg, R.A. Dwek, and T.M. Block. 1999. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. USA 96, 11878-11882